These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 29909706)
1. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor. Lee SY; Choi JW; Lee JY; Kim DD; Kim HC; Cho HJ Drug Deliv; 2018 Nov; 25(1):1472-1483. PubMed ID: 29909706 [TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor. Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730 [TBL] [Abstract][Full Text] [Related]
3. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery. Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169 [TBL] [Abstract][Full Text] [Related]
4. Interconnected hyaluronic acid derivative-based nanoparticles for anticancer drug delivery. Park JH; Cho HJ; Termsarasab U; Lee JY; Ko SH; Shim JS; Yoon IS; Kim DD Colloids Surf B Biointerfaces; 2014 Sep; 121():380-7. PubMed ID: 24993066 [TBL] [Abstract][Full Text] [Related]
5. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Cho HJ; Yoon IS; Yoon HY; Koo H; Jin YJ; Ko SH; Shim JS; Kim K; Kwon IC; Kim DD Biomaterials; 2012 Feb; 33(4):1190-200. PubMed ID: 22074664 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma. Jin YJ; Termsarasab U; Ko SH; Shim JS; Chong S; Chung SJ; Shim CK; Cho HJ; Kim DD Pharm Res; 2012 Dec; 29(12):3443-54. PubMed ID: 22886625 [TBL] [Abstract][Full Text] [Related]
7. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy. Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259 [TBL] [Abstract][Full Text] [Related]
8. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid. Wang X; Gu X; Wang H; Yang J; Mao S Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965 [TBL] [Abstract][Full Text] [Related]
9. Tumor Targeting and Lipid Rafts Disrupting Hyaluronic Acid-Cyclodextrin-Based Nanoassembled Structure for Cancer Therapy. Lee SY; Ko SH; Shim JS; Kim DD; Cho HJ ACS Appl Mater Interfaces; 2018 Oct; 10(43):36628-36640. PubMed ID: 30298719 [TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly[lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection. Hsu MY; Huang YT; Weng CJ; Chen CM; Su YF; Chu SY; Tseng JH; Wu RC; Liu SJ Colloids Surf B Biointerfaces; 2020 Jun; 190():110937. PubMed ID: 32155454 [TBL] [Abstract][Full Text] [Related]
11. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery. Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433 [TBL] [Abstract][Full Text] [Related]
13. Monodisperse CaCO Chen M; Guo X; Shen L; Ding J; Yu J; Chen X; Wu F; Tu J; Zhao Z; Nakajima M; Song J; Shu G; Ji J Int J Biol Macromol; 2023 Mar; 231():123160. PubMed ID: 36610575 [TBL] [Abstract][Full Text] [Related]
14. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery. Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720 [TBL] [Abstract][Full Text] [Related]
15. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma. Kwak K; Yu B; Mouli SK; Larson AC; Kim DH J Vasc Interv Radiol; 2020 Oct; 31(10):1697-1705.e3. PubMed ID: 32773247 [TBL] [Abstract][Full Text] [Related]
16. Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor. Choi JW; Park JH; Cho HR; Chung JW; Kim DD; Kim HC; Cho HJ Sci Rep; 2017 Apr; 7(1):554. PubMed ID: 28373713 [TBL] [Abstract][Full Text] [Related]
17. Gas generating microspheres for immediate release of Hsp90 inhibitor aiming at postembolization hypoxia in transarterial chemoembolization therapy of hepatocellular carcinoma. Choi JW; Lee SY; Cho EJ; Jeong DI; Kim DD; Kim HC; Cho HJ Int J Pharm; 2021 Sep; 607():120988. PubMed ID: 34389420 [TBL] [Abstract][Full Text] [Related]
18. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence. Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690 [TBL] [Abstract][Full Text] [Related]
19. Development and physicochemical characterization of a biodegradable microspheres formulation loaded with samarium-153 and doxorubicin for chemo-radioembolization of liver tumours. Alregib AH; Tan HY; Wong YH; Kasbollah A; Wong EH; Abdullah BJJ; Perkins AC; Yeong CH J Labelled Comp Radiopharm; 2023 Aug; 66(10):308-320. PubMed ID: 37287213 [TBL] [Abstract][Full Text] [Related]
20. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery. Hang C; Zou Y; Zhong Y; Zhong Z; Meng F Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]